Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series-Reference-Cited by-同舟云学术

Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series

Published:2019-06-27 Issue:13 Volume:60 Page:3292-3295
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Rafei Hind¹^ORCID,Jabbour Elias Joseph²,Kantarjian Hagop²,Sinicrope Kaylyn D.³,Kamiya-Matsuoka Carlos³,Mehta Rohtesh S.⁴,Daver Naval G.²,Kadia Tapan M.²,Naqvi Kiran²,Cortes Jorge²,Konopleva Marina²

Affiliation:

1. Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

2. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

3. Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA;

4. Departement of Stem Cell Transplant and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2019.1633635

Reference18 articles.

1. Second-Generation Tyrosine Kinase Inhibitors: The Future of Frontline CML Therapy

2. Gleevec® (imatinib mesylate) package insert, East Hanover, NJ: Novartis. 2016.

3. Sprycel® (dasatinib) package insert, Princeton, NJ: Bristol-Myers Squibb. 2015.

4. Tasigna® (nilotinib) package insert, East Hanover, NJ: Novartis. 2015.

5. Bosulif® (bosutinib) package insert, New York, NY: Pfizer. 2016.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neuro-ophthalmic complications of modern anti-cancer drugs;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-02-12

2. Drug-related immune-mediated myelopathies;Frontiers in Neurology;2022-09-29

3. Role of inflammation and oxidative stress in chemotherapy-induced neurotoxicity;Immunologic Research;2022-07-20

4. Intracranial hypertension associated with BCR-ABL1 tyrosine kinase inhibitors in chronic myeloid leukemia;Leukemia & Lymphoma;2022-04-01

5. c‐Abl ‐induced Olig2 phosphorylation regulates the proliferation of oligodendrocyte precursor cells;Glia;2022-02-13